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he interaction of talin with phosphatidylinositol(4)
phosphate 5 kinase type I
 
 
 
 (PIPKI
 
 
 
) regulates
PI(4,5)P
 
2
 
 synthesis at synapses and at focal adhe-
sions. Here, we show that phosphorylation of serine 650
(S650) within the talin-binding sequence of human PIPKI
 
 
 
blocks this interaction. At synapses, S650 is phosphory-
lated by p35/Cdk5 and mitogen-activated protein kinase
at rest, and dephosphorylated by calcineurin upon stimu-
lation. S650 is also a substrate for cyclin B1/Cdk1 and
its phosphorylation in mitosis correlates with focal adhe-
sion disassembly. Phosphorylation by Src of the tyrosine
adjacent to S650 (Y649 in human PIPKI
 
 
 
) was shown to
T
 
enhance PIPKI
 
 
 
 targeting to focal adhesions (Ling, K., R.L.
Doughman, V.V. Iyer, A.J. Firestone, S.F. Bairstow, D.F.
Mosher, M.D. Schaller, and R.A. Anderson. 2003. 
 
J. Cell
Biol.
 
 163:1339–1349). We ﬁnd that Y649 phosphorylation
does not stimulate directly PIPKI
 
 
 
 binding to talin, but
may do so indirectly by inhibiting S650 phosphorylation.
Conversely, S650 phosphorylation inhibits Y649 phos-
phorylation by Src. The opposite effects of the phosphor-
ylation of Y649 and S650 likely play a critical role in
regulating synaptic function as well as the balance between
cell adhesion and cell motility.
 
Introduction
 
Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P
 
2
 
), a phospho-
inositide highly enriched at the plasma membrane, plays a key
role in intracellular signaling (De Camilli et al., 1996; Martin,
1998; Takenawa and Itoh, 2001; Yin and Janmey, 2003). The
main pathway for the generation of PI(4,5)P
 
2
 
 is phosphorylation
of phosphatidylinositol(4)phosphate (PI(4)P) by the so-called
type I PIP kinases, which function primarily as PI(4)P 5-kinases
(Ishihara et al., 1998). The three catalytically active members
of this family differ in cellular and subcellular distribution
and, thus, control specific PI(4,5)P
 
2
 
 pools (Doughman et al.,
2003). PIP kinase type I
 
 
 
 (PIPKI
 
 
 
), which is expressed at high
levels in the brain, comprises splice variants (PIPKI
 
 
 
87 and
PIPKI
 
 
 
90) that differ because of the presence of a 28-aa tail
(Ishihara et al., 1998). An additional splice variant that contains
a 26-aa insert before the 28-aa tail was described recently
(Giudici et al., 2004). Via the sequence WVYSPL contained
within the 28-aa tail, PIPKI
 
 
 
90 interacts with, and is activated
by, talin (Di Paolo et al., 2002; Ling et al., 2002), which is an
adaptor between the cytoplasmic domain of most 
 
 
 
 integrins
(cell-surface receptors involved in cell adhesion) and the actin
cytoskeleton (Calderwood and Ginsberg, 2003). Isoforms in-
cluding the 28-aa tail predominate in brain, where they are
concentrated at synapses (Di Paolo et al., 2002, 2004; Wenk et
al., 2001). Accordingly, talin is present at synapses (Di Paolo et
al., 2002; Morgan et al., 2004), and the relatively smaller pools
of PIPKI
 
 
 
90 present in nonneuronal cells are concentrated at
focal adhesion sites (Di Paolo et al., 2002; Ling et al., 2002).
Disruption of the talin–PIPKI
 
 
 
90 interaction at synapses dis-
rupts synaptic vesicle recycling and actin dynamics (Morgan et
al., 2004), while its perturbation in nonneuronal cells affects
cell adhesion (Di Paolo et al., 2002; Ling et al., 2002).
Binding of talin to the cytoplasmic domain of integrin 
 
 
 
subunits induces conformational changes in the extracellular
portion of the 
 
 
 
/
 
 
 
 integrin dimer leading to increased affinity
for extracellular ligands (the so-called inside-out signaling)
(Hynes, 2002; Calderwood and Ginsberg, 2003). Conversely,
cell adhesion to substrates induces the nucleation of focal adhe-
sions and the nucleation of the associated actin cytoskeleton.
PI(4,5)P
 
2
 
 is known to play an important regulatory role in this
bidirectional signaling by its interactions with many proteins of
focal adhesions, including talin (Martel et al., 2001; Takenawa
and Itoh, 2001; Yin and Janmey, 2003). Talin binds to PIPKI
 
 
 
90
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via its band 4.1/ezrin/radixin/moesin (FERM) domain, primarily
by its F3 subdomain (Di Paolo et al., 2002; Ling et al., 2002),
which also comprises the binding site for 
 
 
 
 integrin (Calder-
wood et al., 1999). In fact, the interactions of PIPKI
 
 
 
90 and 
 
 
 
 in-
tegrin with the F3 subdomain are mutually exclusive (Barsukov
et al., 2003). Accordingly, overexpression of constructs compos-
ing the 28-aa tail of PIPKI
 
 
 
90 produces a “trans-dominant in-
hibition” of integrin function, by competing for its binding to
talin (Calderwood et al., 2004). The tyrosine of the sequence
WVYSPL undergoes endogenous phosphorylation by Src (Ling
et al., 2003). This phosphorylation reaction, which may contrib-
ute to the stimulatory effect of focal adhesion kinase on focal
adhesions, was reported to enhance the interaction between
PIPKI
 
 
 
90 and talin’s F3 subdomain, which has a phosphoty-
rosine binding domain-like fold (Garcia-Alvarez et al., 2003).
PIPKI
 
 
 
, in concert with the polyphosphoinositide phos-
phatase synaptojanin (Cremona et al., 1999), plays an im-
portant regulatory function in synaptic physiology. Based on
genetic studies and other experimental approaches, it was
proposed that PIPKI
 
 
 
 controls a plasma membrane pool of
PI(4,5)P
 
2
 
 implicated in synaptic vesicle exo-endocytosis (Wenk
et al., 2001; Di Paolo et al., 2004) and that synaptojanin
dephosphorylates PI(4,5)P
 
2
 
 during the endocytic reaction (Cre-
mona et al., 1999; Wenk and De Camilli, 2004). At synapses,
both PIPKI
 
 
 
 (Wenk et al., 2001) and synaptojanin (Lee et al.,
2004), as well as several other proteins implicated in vesicle re-
cycling and actin function (Bauerfeind et al., 1997; Cousin and
Robinson, 2001; Tan et al., 2003; Tomizawa et al., 2003), un-
dergo constitutive phosphorylation and stimulation-dependent,
Ca
 
2
 
 
 
-dependent dephosphorylation. At least for some of these
proteins, phosphorylation at rest as well as rapid rephosphory-
lation after a depolarization stimulus is mediated by Cdk5 (Tan
et al., 2003; Tomizawa et al., 2003; Lee et al., 2004). Con-
versely, dephosphorylation is mediated by the Ca
 
2
 
 
 
-dependent
phosphatase calcineurin (Bauerfeind et al., 1997; Cousin and
Robinson, 2001). In the case of synaptojanin 1, its dephosphor-
ylation by calcineurin triggers its recruitment and activation at
endocytic sites from a cytosolic pool (Lee et al., 2004).
The goal of the present study was to examine the regula-
tion by phosphorylation of PIPKI
 
 
 
90. Our results demonstrate
that S650 within the talin-binding sequence WVYSPL is a
main target of regulation by phosphorylation and that S650
phosphorylation blocks talin binding. Furthermore, a mutu-
ally antagonistic relationship exists between Src and proline-
directed kinases with regard to the phosphorylation of adjacent
sites on PIPKI
 
 
 
90, thereby providing a mechanism for the bidi-
rectional modulation of interactions between PIPKI
 
 
 
90 and
talin. This regulation is not restricted to synapses and may play
an important and general function at focal adhesions.
 
Results
 
p35/Cdk5 phosphorylates PIPKI
 
 
 
90 at 
serine 650
 
As a first step to determine whether Cdk5 may be responsible, at
least in part, for the constitutive phosphorylation of PIPKI
 
 
 
90 in
resting synapses, we tested the ability of PIPKI
 
 
 
90 to serve as a
substrate for Cdk5 in vitro. Incubation of GST fusion protein of
human PIPKI
 
 
 
90 with purified p35/Cdk5 at an 
 
 
 
1:1 stoichiomet-
ric ratio resulted in its efficient phosphorylation (Fig. 1 A). Simi-
lar results were obtained with His
 
6
 
-tagged PIPKI
 
 
 
90 (Fig. 1 B),
which was used for all subsequent phosphorylation experiments.
p35, a prominent physiological substrate for the kinase activity of
Cdk5 (Dhavan and Tsai, 2001), was also efficiently phosphory-
lated, as expected, and with similar kinetics during a 30-min incu-
bation (Fig. 1 C). Two Cdk5 inhibitors, roscovitine (Tan et al.,
2003) and butyrolactone I (Lee et al., 2004), inhibited the phos-
phorylation of both proteins (Fig. 1 A). A stoichiometric analysis
revealed the incorporation of 2 mol phosphate/mol PIPKI
 
 
 
90,
which suggests at least two phosphorylation sites (Fig. 1 D).
To identify the residues phosphorylated by Cdk5, His
 
6
 
-
PIPKI
 
 
 
90 was phosphorylated by p35/Cdk5 in the presence of
Figure 1. PIPKI 90 is phosphorylated by p35/Cdk5 at S650 in vitro.
Recombinant PIPKI 90 fusion proteins were incubated with p35–Cdk5
complex in the presence of [
32P]ATP for 30 min. Protein phosphorylation
was analyzed by autoradiography after SDS-PAGE. (A) GST-PIPKI 90
was phosphorylated by p35/Cdk5 in the absence and presence of the
Cdk5 inhibitors, roscovitine or butyrolactone I (20  M each). (B and C)
Phosphorylation of His6-PIPKI 90 by p35/Cdk5 and time course of the
phosphorylation. (D) Stoichiometry of the phosphorylation of His6-
PIPKI 90 by p35/Cdk5. Purified proteins phosphorylated in vitro in the
presence of [
32P]ATP were separated by SDS-PAGE and stained with Coo-
massie brilliant blue. PIPKI 90 bands were excised and incorporation of
32P was measured. (E) Diagram indicating the position of the phosphorylation
site S650 in the COOH-terminal 28-aa tail of PIPKI 90. (F) 2-D phospho-
peptide mapping of His6-PIPKI 87, His6-PIPKI 90, and S650A mutant
His6-PIPKI 90 phosphorylated by p35/Cdk5 for 30 min in vitro. A circle
outlines the spots present only in the protein that contains S650. 
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90 PHOSPHORYLATION BY PROLINE-DIRECTED PROTEIN KINASES • LEE ET AL.
 
791
 
32
 
P[ATP] and subjected to trypsin fragmentation followed by
HPLC separation. Matrix-assisted laser desorption ionization/
mass spectrometry (MALDI/MS) analysis and Edman radio-
sequencing of the major radioactive peptide identified serine 650
(S650) (human sequence) as likely being a major site of phos-
phorylation. S650 is found within the sequence (S/T)PX(H/K/R)
that fits the known Cdk5 consensus motif (Dhavan and Tsai,
2001). Notably, this sequence is part of the talin-binding site
(Fig. 1 E; Di Paolo et al., 2002). The identification of S650 was
confirmed by two-dimensional (2-D) phosphopeptide mapping
of in vitro–phosphorylated His
 
6
 
-PIPKI
 
 
 
90 and His
 
6
 
-PIPKI
 
 
 
87
(Fig. 1 F), which differ only by the presence or absence of the
28-aa tail. Although several identical radioactive peptides were
observed for both isoforms, one major peptide and an adjacent
accessory peptide (Fig. 1 F, circled region) were observed only
for PIPKI
 
 
 
90 (Fig. 1 F). Phosphorylation of these two peptides
saturated more rapidly than the other peptides based on compari-
son of autoradiograms obtained from 5-, 30-, and 60-min phos-
phorylation reactions (unpublished data). When S650 was
mutated to alanine (S650A), these peptides were no longer ob-
served. These data indicate that, at least in vitro, S650 is the
 
 
 
most
rapidly phosphorylated, although not the only, site for Cdk5 in
PIPKI
 
 
 
90. Two other sites, serine 453 and threonine 123, that
are common to PIPKI
 
 
 
90 and PIPKI
 
 
 
87 fit the Cdk5 consensus
motif. Preliminary experiments indicate that Cdk5 may phos-
phorylate S453; in contrast, mutation of T123 to alanine did not
alter the 2-D phosphopeptide mapping pattern (unpublished
data). In this study, we have focused on S650 because of its loca-
tion within the minimal talin-binding motif (WVYSPL).
To further confirm the site of phosphorylation and for use
in the studies described later, an antibody that specifically
recognizes PIPKI
 
 
 
90 phosphorylated at S650 (anti–phospho-
S650 [pS650] antibody) was raised. The pS650 antibody selec-
tively recognized WT PIPKI
 
 
 
90 phosphorylated in vitro by
p35/Cdk5 (Fig. 2 A). Under the same conditions (after 30-min
incubation), the S650A mutant was phosphorylated to a much
lower extent as revealed by the incorporation of 
 
32
 
P (reflecting
one or other phosphorylation sites besides S650), and no sig-
nal was detected with the pS650 antibody (Fig. 2 A). WT or
S650A HA-PIPKI
 
 
 
90 was transfected into CHO cells with p35
plus Cdk5. Using the pS650 antibody to analyze immunopre-
cipitated PIPKI
 
 
 
90, the WT, but not the S650 mutant, protein
was found to be phosphorylated (Fig. 2 B). Omission of p35
and Cdk5, or transfection with catalytically inactive mutant of
Cdk5 (mut-Cdk5; Patrick et al., 1999) resulted in a signifi-
cantly lower phosphorylation of S650 compared with that ob-
served after transfection with p35/Cdk5 (Fig. 2 C). Under these
conditions, S650 may be phosphorylated by low levels of en-
dogenous Cdk5 (Dhavan and Tsai, 2001) and/or by other pro-
line-directed protein kinases (see Figs. 7 and 8).
 
Phosphorylation of S650 inhibits the 
interaction of PIPKI
 
 
 
90 with talin in 
vitro and in vivo
 
Given the location of S650 in the middle of the talin-binding se-
quence (WVYSPL; Di Paolo et al., 2002), the possibility that
phosphorylation of S650 of PIPKI
 
 
 
90 inhibits its interaction
with talin was next examined. Isothermal titration calorimetry
(ITC) was used to analyze the binding of the GST-talin head (Di
Paolo et al., 2002), which comprises the FERM domain, to syn-
thetic 12-mer dephospho- and phosphopeptides encompassing
the talin-binding sequence of PIPKI
 
 
 
90. 
 
K
 
d
 
 values of 2 
 
 
 
M and
 
 
 
1 mM were observed for the dephosphopeptide and the pS650
peptide, respectively (Fig. 3 A), indicating a strongly negative
role of S650 phosphorylation in talin binding. A 
 
K
 
d
 
 of 2 
 
 
 
M (see
Fig. 6 A) value for the WT peptide is in agreement with the dis-
sociation constant of the same interaction measured with tryp-
tophan fluorescence by Barsukov et al. (2003), but is higher than
the dissociation constant observed by Ling et al. (2003) using
fluorescence anisotropy measurement. Differences in the assays
and the experimental conditions may explain the discrepancy.
For example, our values were obtained at 37
 
o
 
C, whereas the
value of Ling et al. (2003) was recorded at room temperature.
We further examined whether the in vivo interaction of
PIPKI
 
 
 
90 with talin is inhibited by Cdk5-dependent phosphor-
ylation. CHO cells were transfected with HA-PIPKI
 
 
 
90, p35,
Figure 2. PIPKI 90 is phosphorylated by p35/Cdk5 at S650 in vivo.
(A) Generation and characterization of a polyclonal antibody specific for
phospho-S650 (pS650). Purified WT and S650A mutant His6-PIPKI 90
were incubated with or without p35/Cdk5 and with either nonradioactive
ATP (for Western blotting) or [
32P]ATP (for autoradiography) for 30 min.
Samples were analyzed by autoradiography, and Western blotting with
the anti-pS650 antibody was performed. Coomassie brilliant blue (CBB)
staining shows loading of equal amounts of substrate proteins. The auto-
radiographic signal was quantified by a phosphorimager analysis and
values were expressed as a percentage of the radioactivity incorporated
into the WT sample. Bar graphs represent mean   SD (n   3). (B) CHO
cells were transfected with WT or S650A mutant HA-PIPKI 90 together
with p35 and Cdk5. PIPKI 90 immunoprecipitates were obtained from
cell lysates 24 h after transfection. S650 phosphorylation and PIPKI 90
expression were analyzed by Western blotting with anti-pS650 and anti-
HA antibodies, respectively. (C) CHO cells were cotransfected with HA-
PIPKI 90, p35, and Cdk5 or mut-Cdk5. PIPKI 90 immunoprecipitates
from transfected and control cells were analyzed by Western blotting as
described above. The faint band visible in nontransfected CHO cells may
represent phosphorylated hamster PIPKI 90. The pS650 immunoreactivity
was quantified using an NIH image analysis software and shown as
mean   SD (n   3).JCB • VOLUME 168 • NUMBER 5 • 2005 792
and either Cdk5 or mut-Cdk5 (as in Fig. 2 C). Cell lysates were
then processed for anti-PIPKI 90 or antitalin immunoprecipi-
tation, and the starting lysates and the resulting pellets were an-
alyzed by Western blotting for transfected and control proteins
(Fig. 3 B). Talin coprecipitated with HA-PIPKI 90, and HA-
PIPKI 90 coprecipitated with talin, as expected. However, ex-
pression of Cdk5, but not mut-Cdk5, strongly inhibited the co-
precipitation of the two proteins.
We next determined whether a phosphomimetic mutation
of S650 to aspartic acid (S650D) affected the interaction with
talin. WT and S650D His6-PIPKI 90 were overlaid in a “far-
Western” assay with a GST fusion protein of the F3 subdomain
of the FERM domain of talin (Fig. 4, A and C). The F3 domain
clearly bound to the WT protein, as expected (Di Paolo et al.,
2002), but no binding was observed for the S650D mutant (Fig.
4 A). Binding of the F3 domain to the S650A mutant was also
reduced, although not abolished, and this is in agreement with a
potential role of the side chain of serine in the binding (Di Pa-
olo et al., 2002; Liddington et al., 2003). These results were
qualitatively confirmed by His6-PIPKI 90 pull-down assays
Figure 3  Cdk5 phosphorylation of PIPKI 90
inhibits its interaction with talin in vivo. (A) ITC
analysis of the binding of 12-mer WT and
pS650 peptides from the 28-aa tail of
PIPKI 90 to GST-talin head. Raw data as a
function of time are shown in the top panels,
and plots of the total heat released as a func-
tion of the molar ratio of each ligand are
shown in the bottom panels. The continuous
line in the bottom panels represents the nonlin-
ear, least-squares best fits to the experimental
data using a one-site model of binding. Note
the roughly 1:1 stoichiometry indicated by the
half-height point of the sigmoidal curve (bottom
left; Turnbull and Daranas, 2003), and the
complete absence of heat release in the case
of the pS650 peptide. (B) CHO cells were
cotransfected with HA-PIPKI 90, p35, and
Cdk5 or mut-Cdk5. Protein contents of the
starting lysates were revealed by Western
blotting. PIPKI 90 and talin were immunopre-
cipitated from the cell lysates and presence of
PIPKI 90 and talin in each immunoprecipitate
was detected by Western blotting.
Figure 4. Phosphomimetic mutation at S650
(S650D) disrupts the interaction of PIPKI 90
with talin in vitro. (A) GST-F3 overlay assay.
Nitrocellulose blots of WT and mutant His6-
PIPKI 90 were overlaid with or without GST-
F3 fusion protein, and then overlaid with anti-
GST antibody. CBB staining reveals equal
load of the lanes. (B) Pull-down assay from rat
brain extracts on bead-immobilized WT and
mutant His6-PIPKI 90. Bound talin was re-
vealed by Western blotting, and equal
amount of bait proteins was revealed by CBB
staining. (C) The intensities of the GST-F3 and
talin bands shown in A and B were quantified
by an NIH image analysis software. Values
from mutant proteins were normalized to that
from WT and are represented as mean   SD
(n   4). (D) Localization of transfected GFP-
PIPKI 90. NIH3T3 cells were transfected with
GFP-PIPKI 90 or its S650D mutant, and then
were processed by immunofluorescence for
vinculin immunoreactivity. Bar, 10  m. (E)
Pull-down assay from lysates of CHO cells
transfected with WT and S650D mutant GFP-
PIPKI 90. Bead-immobilized GST-integrin  1
tail was used as a bait. Talin and PIPKI 90 in
the lysates or bead fractions were detected by
Western blotting. (F) NIH3T3 cells transfected
with mutant (S650N) GFP-PIPKI 90 were im-
munostained with antivinculin antibody. Bar,
10  m. (G) CHO cells were transfected with WT, S650D, or S650N GFP-PIPKI 90. After 24 h of transfection, cell lysates were immunoprecipitated with
anti-PIPKI 90 antibody, and the presence of talin and PIPKI 90 in the immunoprecipitates was analyzed by Western blotting.PIPKI 90 PHOSPHORYLATION BY PROLINE-DIRECTED PROTEIN KINASES • LEE ET AL. 793
from rat brain extracts (Fig. 4, B and C). In this case, the loss of
binding produced by the S650A mutation was nearly as large
as that produced by the S650D mutation.
The effect of the phosphomimetic S650D mutation on the
properties of PIPKI 90 was further investigated in living cells.
WT, but not mutant (S650D) GFP-PIPKI 90, accumulated at fo-
cal adhesions when expressed in NIH3T3 cells (mouse fibro-
blast), as shown by colocalization with the focal adhesion marker
vinculin (Fig. 4 D). This result demonstrates the inhibitory effect
of the presence of an acidic charge at position 650 in the recruit-
ment of PIPKI 90 at focal adhesions, which is consistent with the
blocking effect on the interaction with talin. As reported previ-
ously, the interaction of talin with PIPKI 90 competes with the
interaction of talin with   integrin, because both proteins bind to
the same surface of talin’s F3 domain (Barsukov et al., 2003; Lid-
dington et al., 2003; Calderwood et al., 2004). Accordingly, pull-
downs with a GST fusion protein of integrin  1 tail from lysates
of CHO cells transfected with mutant (S650D) or wild-type
PIPKI 90 yielded a higher level of talin in the case of cells trans-
fected with the mutant protein, which is not expected to compete
(Fig. 4 E). Collectively, these results indicate that talin binding is
incompatible with the presence of a negative charge at S650 in
PIPKI 90 and that S650 phosphorylation has an important role in
the regulation of PIPKI 90–talin–integrin interactions.
PIPKI 90 and   integrin share amino acid similarity in
the talin-binding region. Within these similar sequences, S650
of PIPKI 90 was proposed to functionally replace the aspar-
agine of the sequence NPXY in   integrin. When S650 of
PIPKI 90 was replaced by an asparagine (S650N), the result-
ing mutant protein was still able to bind to talin, confirming
this prediction. Thus, transfected GFP-PIPKI 90 harboring the
S650N mutation colocalized with vinculin at focal adhesions
(Fig. 4 F) and coprecipitated with talin from lysates of trans-
fected cells (Fig. 4 G). The presence of a serine at this position
in PIPKI 90, but not in   integrin, allows for a differential reg-
ulation of the two interactions by phosphorylation.
If the binding of PIPKI 90 to talin is important for focal
adhesion dynamics, overexpression of p35/Cdk5 would be ex-
pected to affect focal adhesion dynamics by enhancing the
phosphorylation state of S650. Consistent with this prediction,
overexpression of p35/Cdk5 in NIH3T3 cells disrupted focal
adhesions and stress fibers, as detected by antivinculin immu-
nostaining and phalloidin staining, respectively (Fig. 5).
PIPKI 90 phosphorylation by Cdk5 and 
Src is mutually exclusive
Ling et al. (2003) reported that the COOH-terminal region of
mouse PIPKI 90 undergoes phosphorylation by Src at tyrosine
644 (Y649 of human PIPKI 90) and that this phosphorylation
enhances its interaction with talin. Y649 is adjacent to S650 in
the talin-binding sequence (WVYSPL), which is identical in
mice and humans. The juxtaposition of the two sites raised the
possibility that phosphorylation of one might regulate phos-
phorylation of the other. This possibility was tested using syn-
thetic peptides centered around the talin-binding consensus.
Both 12-mer peptides, as well as 17-mer peptides identical to
those used by Ling et al. (2003), were tested. First, we revisited
the effect of Y649 phosphorylation on talin binding. Surpris-
ingly, an ITC assay did not demonstrate a difference between
the affinities of the WT peptides and of the pY649 peptides for
GST-talin head (Fig. 6 A). Phosphorylation of tyrosine 654,
which is a weak Src target site (Ling et al., 2003), also had no
positive effect on talin binding, and in fact, it slightly decreased
the binding (Fig. 6 A). The pS650 12-mer peptide exhibited
negligible binding to talin, as expected (Figs. 6 A and 3 A). In
agreement with the results of the ITC assay, the WT peptide
(12-mer) and the pY649 peptide (12-mer) equally competed
with the tail for talin binding in pull-down assays from rat brain
extracts using GST–28-aa tail (unpublished data).
Next, we tested whether the presence of a phosphate at po-
sition 649 or 650 affected the phosphorylation of the adjacent
site. The 12-mer WT, pY649, and pS650 peptides were incu-
bated under linear rate conditions with purified c-Src or p35/
Cdk5 and 
32P[ATP]. The pY649 peptide was a poor substrate for
Cdk5 (Fig. 6 B). Likewise, the pS650 peptide was a poor sub-
strate for c-Src. As expected, the pY649 and pS650 peptides
were hardly phosphorylated by c-Src and Cdk5, respectively.
These data suggest that phosphorylation of either site has a
strong inhibitory effect on the phosphorylation of the other site.
S650 phosphorylation of PIPKI 90 is 
regulated by Cdk5 and calcineurin at 
synapses
In the next series of experiments, the in vivo phosphorylation of
S650 in endogenous PIPKI 90 was investigated. Rat brain syn-
Figure 5. Inhibitory effects of p35/Cdk5 overexpression on focal adhesion.
NIH3T3 cells were cotransfected with both p35 and Cdk5 for 24 h, and
the overexpressed proteins were detected by immunofluorescence micros-
copy with the antibodies indicated. Focal adhesions were visualized by
antivinculin immunostaining, and actin was visualized by fluorescent phalloi-
din. Bar, 10  m.JCB • VOLUME 168 • NUMBER 5 • 2005 794
aptosomes, including samples exposed to a 1-h metabolic label-
ing step with 
32Pi, were incubated for 20 min in control buffer,
and then were depolarized for 1 min with high K
  (55 mM) in
the absence or presence of extracellular Ca
2 . As detected by
using 
32P incorporation or by using the pS650 antibody, we
found that PIPKI 90 was constitutively phosphorylated at rest,
and dephosphorylated upon high K
  stimulation, but only in the
presence of extracellular Ca
2  (Fig. 7 A). The stimulation-
dependent dephosphorylation of pS650 was blocked by cy-
closporin A, a calcineurin inhibitor (Fig. 7 B). Furthermore, re-
phosphorylation of S650 upon reexposure to the control buffer
was partially inhibited by incubation with butyrolactone I (Fig.
7 C) or roscovitine (unpublished data). The pattern of PIPKI 90
dephosphorylation was qualitatively similar to that of am-
phiphysin 2, whose upper band (phospho-form) collapses into
lower bands (dephospho form) upon calcineurin-dependent de-
phosphorylation (Fig. 7 A; Bauerfeind et al., 1997; Cousin and
Robinson, 2001).
The only partial effect of Cdk5 inhibitors on the phos-
phorylation of S650 suggested that other kinases may phosphor-
ylate this site. Interestingly, the phosphorylation/dephosphor-
ylation of S650 in resting and stimulated synaptosomes was
reminiscent of that of the phosphorylation sites 4 and 5 of syn-
apsin I (corresponding to serine 62 and serine 67, respectively,
of rat synapsin I) (Fig. 7 B; Jovanovic et al., 2001). Notably,
these sites in synapsin I were found to be phosphorylated by
MAPK (Jovanovic et al., 2001). MAPK is a proline-directed
serine/threonine kinase whose substrate specificity [(S/T)P]
(Songyang et al., 1996) overlaps with the substrate preference
of Cdk5 and may therefore be involved in S650 phosphoryla-
tion.
The potential involvement of MAPK as well as of phos-
phatases other than calcineurin in the regulation of S650 phos-
phorylation was investigated. Synaptosomes were treated with
either okadaic acid, an inhibitor of protein phosphatase 2A
(PP2A), or PD98059, an inhibitor of MAPK1/2 (p42/p44).
Okadaic acid alone strongly enhanced the phosphorylation
state of S650 both at rest and after high K
  depolarization (Fig.
7 D), although a stimulation-dependent dephosphorylation of
S650 still occurred upon exposure to high K
  (Fig. 7 D, com-
pare the second and fourth lanes). Okadaic acid also increased
the level of phospho-MAPK1/2 (Fig. 7 D). This was expected
because PP2A is known to dephosphorylate MAPK, with a re-
sulting inhibition of its activity (Alessi et al., 1995). PD98059
partially prevented the increase in S650 phosphorylation pro-
duced by okadaic acid (Fig. 7 E). The increase of pS650 pro-
duced by okadaic acid may result both from a direct inhibition
of pS650 dephosphorylation by PP2A and/or indirectly from
the enhanced MAPK activity caused by inhibition of PP2A.
Note that, as previously reported, depolarization in the pres-
ence of extracellular Ca
2  increases the phosphorylation state
of MAPK1/2 (Fig. 7 D, compare the first and third lanes;
Yamagata et al., 2002). This is in contrast to the depolarization-
dependent dephosphorylation of S650, thus indicating that cal-
cineurin can override the action of MAPK on S650. Consistent
with PIPKI 90 being a substrate for MAPK, purified MAPK1
phosphorylated S650 in WT His6-PIPKI 90 in vitro, but did
not phosphorylate S650A mutant His6-PIPKI 90 (Fig. 7 F), as
determined by anti-p5650 Western blotting.
S650 of PIPKI 90 undergoes mitotic 
phosphorylation
Entry of cells into mitosis is accompanied by massive struc-
tural changes. For example, cells grown in culture round up
and partially detach from the substrates, a change which corre-
lates with the disruption of focal adhesions (Maddox and Bur-
ridge, 2003). The property of S650 of PIPKI 90 to function as
a substrate for Cdk5, a member of the Cdk family, prompted us
to examine its phosphorylation state during mitosis. Disruption
of the interaction between talin and PIPKI 90 could be one of
the biochemical modifications that correlate with focal adhe-
sion disassembly. CHO cells transfected with WT or mutant
HA-PIPKI 90 were either treated with nocodazole to arrest
cells in pro-metaphase, or treated with nocodazole and then al-
lowed to progress to G1 interphase by re-addition of serum.
pS650 immunoreactivity was detected only in cells expressing
WT PIPKI 90 and phosphorylation was dramatically increased
in mitotic cells (Fig. 8 A). These results were corroborated by
the analysis of endogenous PIPKI 90 in cells (U87MG cells,
derived from a human astrocytoma) that express high levels of
this enzyme. In this case, cell lysates were subjected to immu-
noprecipitation with anti-PIPKI 90 antibody prior to West-
ern blotting (Fig. 8 B). Not only S650 phosphorylation was
strongly stimulated in mitosis, but coprecipitation of talin with
Figure 6. Phosphorylation of either Y649 or S650 inhibits the phosphor-
ylation of the adjacent site. (A) Binding of PIPKI 90 peptides to GST-talin
head as determined by ITC. Note that both the dissociation constant (Kd)
and the enthalpy ( H) of the binding are similar for WT and pY649 pep-
tides. The pY654 peptide has lower affinity, but the pS650 peptide did
not bind. N/A, not available. (B) In vitro phosphorylation by Cdk5 and
c-Src of WT, pY649 and pS650 12-mer PIPKI 90 peptides. Each pep-
tide was incubated in the presence of [
32P]ATP and of either p35/Cdk5
or c-Src for 20 min at 30 C. Peptides were then recovered on phospho-
cellulose paper, and the associated radioactivity was measured by
Cerenkov counting. Incorporation of radioactivity into pY649 and
pS650 peptides was normalized to that of the WT peptide and presented
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the kinase was nearly abolished in the mitotic state. The mitotic
synchronization of these cells was validated by Western blot-
ting of total lysates with antibodies directed against phospho-
histone H3, a marker of mitosis (Ajiro et al., 1996). In support
of a role for cyclin-activated kinases in the phosphorylation
of PIPKI 90 during mitosis, purified cyclin B1–Cdk1 com-
plex phosphorylated purified WT His6-PIPKI 90 in vitro but
weakly phosphorylated its S650A mutant (Fig. 8 C). Cyclin
B1, a physiological substrate of Cdk1 (Borgne et al., 1999),
was phosphorylated at roughly similar levels in both samples
(Fig. 8 C).
Discussion
We and others have recently identified an interaction between
talin and PIPKI 90 that plays an important role at synapses and
focal adhesions (Di Paolo et al., 2002; Ling et al., 2002). This
interaction is thought to control the synthesis of specific pools
of PI(4,5)P2 at these sites, but has an additional impact on adhe-
sion. PIPKI 90 competes with the binding of integrin to talin
and can, therefore, transdominantly inhibit integrin activation
(Barsukov et al., 2003; Calderwood et al., 2004). Thus, the
binding of PIPKI 90 to talin must be highly regulated. Ling et
al. (2003) suggested one mechanism for positive regulation as
being the Src-dependent phosphorylation of Y649 within the
talin-binding sequence WVYSPL. We have now identified and
characterized another mechanism, phosphorylation of S650,
that negatively regulates the talin–PIPKI 90 interaction and
that is the point of convergence of multiple signaling pathways.
In addition, our results suggest that Src-mediated phosphoryla-
tion of Y649 likely acts indirectly on talin binding, rather than
directly, as previously proposed (Ling et al., 2003).
At synapses, the generation of PI(4,5)P2 by PIPKI  is
thought to play an important regulatory role both in exocytosis
and in endocytosis (Wenk et al., 2001; Di Paolo et al., 2004;
Wenk and De Camilli, 2004). The initial goal of this study was
to determine whether PIPKI 90, like several other synaptic
proteins that participate in synaptic vesicle traffic, primarily
endocytic traffic (Bauerfeind et al., 1997; Cousin and Robin-
son, 2001; Tan et al., 2003; Tomizawa et al., 2003; Lee et al.,
2004), is regulated by the serine/threonine phosphorylation.
We have now demonstrated that PIPKI 90 is efficiently phos-
phorylated at S650 by Cdk5 both in vitro and in vivo, and that
this Cdk5 site is dephosphorylated by calcineurin. Importantly,
we have shown that phosphorylation of this site negatively reg-
ulates the talin–PIPKI 90 interaction. Such an interaction is vi-
tal for synaptic physiology, because its perturbation by pep-
tides microinjected into giant axons perturbs synaptic vesicle
recycling and the dynamics of presynaptic actin (Morgan et al.,
2004). Restoration of the interaction by depolarization-trig-
gered dephosphorylation may serve to recruit and activate
PIPKI 90 at sites of exo-endocytosis and may underlie, to-
gether with interaction of PIPKI 90 with small GTPases
(Aikawa and Martin, 2003; Krauss et al., 2003), the increase in
PI(4,5)P2 synthesis occurring in stimulated synaptosomes (Di
Paolo et al., 2004). Interestingly, in preliminary experiments,
we have found that a guanyl nucleotide–independent interac-
tion of PIPKI 90 with Rac1 is also inhibited by Cdk5-depen-
Figure 7. Regulation of S650 phosphorylation in synap-
tosomes. In all panels shown in the figure, with the excep-
tion of E and F, levels of total PIPKI 90 and of its pS650
epitope were analyzed by Western blots of anti-PIPKI 90
immunoprecipitates obtained from synaptosomal lysates.
For other proteins, Western blots were performed directly
on synaptosomal lysates. (A) Freshly prepared rat brain
synaptosomes, or synaptosomes exposed to a 1-h labeling
step with 
32Pi, were incubated for 1 min with either con-
trol buffer or stimulation buffer (high K
 ) in the absence
or presence of Ca
2  (Bauerfeind et al., 1997). Anti-
PIPKI 90 immunoprecipitates prepared from these sam-
ples were analyzed by autoradiography (
32P-labeled
samples) or by Western blotting for pS650 and total
PIPKI 90. Western blotting for amphiphysin 2 revealed
the previously described stimulation-dependent mobility
shift of the upper band (because of its dephosphoryla-
tion), thus confirming the occurrence of Ca
2 -dependent
stimulation. (B) Synaptosomes were stimulated with high
K
  for 1 min in the absence or presence of 2  M cy-
closporin A, and then were analyzed with antibodies di-
rected against pS650 or phospho-sites 4 and 5 (MAPK
sites) of synapsin I. (C) Synaptosomes were exposed for 1
min to either control buffer (resting) or high K
  buffer
(depolarization). Aliquots of stimulated synaptosomes
were then returned for 15 min to control buffer (repolar-
ization) with and without the Cdk5 inhibitor butyrolac-
tone I (10  M). (D) Synaptosomes were incubated for 1
min with control buffer or high K
  buffer in the absence
or presence of 1  M okadaic acid, and then were ana-
lyzed for levels of pS650, PIPKI 90, phospho-MAPK1/2,
and total MAPK1/2. (E) Synaptosomes were stimulated
for 1 min in the absence or presence of 1  M okadaic acid and the MAPK inhibitor PD98059. (F) In vitro phosphorylation of WT and S650A mutant His6-
PIPKI 90 with purified MAPK1. S650 phosphorylation by MAPK1 was detected by the anti-pS650 antibody.JCB • VOLUME 168 • NUMBER 5 • 2005 796
dent phosphorylation at a site distinct from S650 (unpublished
data). These findings support a model according to which
Cdk5 phosphorylation keeps the synapse in a “resting mode,”
whereas calcineurin triggers an “active mode” (Lee et al.,
2004; Sahin and Bibb, 2004).
Our results suggest that phosphorylation of S650 may
also be regulated by other proline-directed kinases and at least
one other phosphatase. A potential role of MAPK can be in-
ferred from the inhibitory action of the MAPK inhibitor
PD98059 on the levels of pS650 in vivo and from the in vitro
phosphorylation of PIPKI 90 by purified MAPK1. The power-
ful stimulatory effect of okadaic acid, an inhibitor of the PP2A
(Jovanovic et al., 2001), on the levels of pS650 is also consis-
tent with an action of MAPK, because PP2A could act indi-
rectly by dephosphorylating and, therefore, inhibiting MAPK
(Alessi et al., 1995). In the presence of okadaic acid, such ac-
tivity would be greatly stimulated. Additionally, PP2A may act
directly on pS650. If this is the case, the large increase of
pS650 observed in the presence of okadaic acid in unstimulated
synaptosomes would indicate the occurrence of a very rapid
turnover of phosphate on S650 even at rest. Among the ques-
tions that remain to be addressed is whether different kinases
and phosphatases act on pools of PIPKI 90 with distinct sub-
cellular localization, because PIPKI 90 is concentrated in, but
not restricted to, nerve terminals. However, important conclu-
sions from this study are that S650 represents the point of con-
vergence of different regulatory pathways and that its state of
phosphorylation controls an important targeting and activation
mechanism of this enzyme.
Cdk5 phosphorylation was found to have only a negligi-
ble (positive) effect on the catalytic activity of PIPKI 90 (un-
published data). Because Cdk5 also phosphorylated PIPKI 87
and slightly activated its catalytic activity (unpublished data),
S650 does not seem to participate in this regulation. How-
ever, it is possible, that sites phosphorylated by other kinases
may directly control its catalytic activity. An inhibitory role on
PIPKI  activity produced by protein kinase A phosphorylation
at serine 264 (human sequence) was previously suggested,
based on studies of the homologous mouse PIPKI  (Park et al.,
2001). The precise coordination of different phosphorylation
reactions remains to be investigated.
Our study also shows that S650 of PIPKI 90 can undergo
phosphorylation in nonneuronal cells, where PIPKI 90 is pri-
marily localized at focal adhesions. However, although trans-
fected Cdk5—a protein kinase expressed predominantly, but
not exclusively, in neurons (Dhavan and Tsai, 2001)—can
phosphorylate transfected PIPKI 90 in CHO cells, the protein
kinase that performs this phosphorylation reaction physiologi-
cally in interphase nonneuronal cells remains to be identified.
As suggested by the phosphomimetic S650D mutant, phos-
phorylation of S650 prevents the localization of PIPKI 90 at
focal adhesions. In addition, the S650D mutant of PIPKI 90
did not compete with the interaction of talin and   integrin.
Therefore, one can expect that regulation of the turnover of
phosphate on S650 may have a key role in the regulation of the
balance between adhesion and motility (Calderwood and Gins-
berg, 2003; Carragher and Frame, 2004). It is of interest, in this
context, that Cdk5 plays a major role in the regulation of cell
migration and neurite outgrowth in the nervous system (Dha-
van and Tsai, 2001; Xie et al., 2003) and of cell adhesion and
migration in nonneuronal cells (Gao et al., 2002). As we have
shown here, its overexpression strongly affects focal adhesion.
As we also show here, S650 of PIPKI 90 undergoes phos-
phorylation in mitosis and is a very good in vitro, and a likely in
vivo, substrate for the cyclin B1–Cdk1 complex. It will be of in-
terest to determine whether phosphorylation of PIPKI 90 at
S650 helps drive focal adhesion disassembly during mitosis, or
simply correlates with this process. We note that other proteins
implicated in membrane traffic at synapses are also physiologi-
cal substrates for both cyclin B1/Cdk1 and p35/Cdk5. These in-
clude epsin, Eps15, and amphiphysin (Chen et al., 1999; Floyd
et al., 2001). Mechanisms that regulate entry into the mitotic
state, where much of the exo-endocytic traffic is blocked (Py-
Figure 8. S650 of PIPKI 90 undergoes mitotic phosphorylation by cyclin
B1/Cdk1. (A) CHO cells transfected with WT or S650A mutant HA-
PIPKI 90 for 24 h were arrested in the mitotic state (M) by nocodazole
treatment. G1 interphase cells (G) were further prepared from mitotically
synchronized cells after removal of nocodazole. Cell lysates of both M
and G cells were analyzed by Western blotting with anti-pS650 and anti-
PIPKI 90 antibodies. (B) U87MG cells were processed as described in A
to generate mitotic and interphase cells. PIPKI 90 was immunoprecipi-
tated from cell lysates for analysis of pS650, talin and total PIPKI 90. Cell
lysates were also analyzed by Western blotting for levels of histone H3
phosphorylation using a phosphospecific antibody. Bar graphs represent
normalized talin immunoreactivity (mean   SD; n   4) after quantification
as shown in Fig. 4 C. (C) WT and S650A mutant His6-PIPKI 90 were incu-
bated in vitro with or without the cyclin B1–Cdk1 complex in the presence
of [
32P]ATP. His6-PIPKI 90 phosphorylation and cyclin B1 autophosphory-
lation were examined by autoradiography after SDS-PAGE. In parallel,
samples phosphorylated under the same conditions with nonradioactive
ATP were processed for Western blotting with anti-pS650 antibody. CBB
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paert et al., 1991), may be closely related to mechanisms that
limit exo-endocytic traffic at neuronal synapses at rest.
At variance with what was reported previously (Ling et
al., 2003), studies with purified peptides, including the same
peptides used by Ling et al. (2003), did not reveal an effect of
Y649 phosphorylation on the interaction of PIPKI 90 with
talin. Furthermore, structural data indicate that phosphorylation
of Y649 would be unlikely to directly perturb the interaction
between these two proteins (Liddington et al., 2003; de Pereda
et al., 2004). In contrast, the negative effect of S650 phosphor-
ylation on the interaction of PIPKI 90 with talin is consistent
with structural predictions pointing to an intimate interaction of
S650 with talin (Liddington et al., 2003) and with the mutagen-
esis experiments reported here.
However, we did find that the presence of phosphate on
Y649 strongly inhibits the phosphorylation of S650, and vice
versa. Thus, Src-dependent phosphorylation of Y649 may act
indirectly to enhance talin binding by inhibiting phosphoryla-
tion of S650. Conversely, in addition to directly blocking the
interaction with talin, phosphorylation of S650, in a feed-for-
ward mechanism, blocks the phosphorylation reaction at Y649
that inhibits S650 phosphorylation. Src family kinases have
been implicated both in synaptic function and in focal adhesion
dynamics (Purcell and Carew, 2003; Carragher and Frame,
2004), thus supporting a physiological significance of this bidi-
rectional control of PIPKI 90.
While our manuscript was in review, a study by de
Pereda et al. (2004) reported a crystallographic analysis of the
interaction between the F3 subdomain of talin and the COOH-
terminal tail of mouse PIPKI . The structure is consistent with
the results of our phosphorylation studies. It predicts that phos-
phorylation of serine 650 of human PIPKI 90 would block the
interaction, and explains the lack of effect that we report here
for the phosphorylation of tyrosine 649. Dissociation constant
values determined by ITC for the talin–PIPKI 90 peptide in-
teraction in this new study (see Fig. S1 in de Pereda et al.,
2004) are in the same range of those reported by us and show
only a minor (1.6-fold) positive effect of phosphorylation of ty-
rosine 644, which corresponds to human tyrosine 649, on the
interaction (de Pereda et al., 2004). Overall, these new findings
are in very good agreement with our results.
Materials and methods
Antibodies
Polyclonal antibodies against human PIPKI 90 and GST were prepared as
described previously (McPherson et al., 1994; Di Paolo et al., 2002). A poly-
clonal anti-GFP antibody was a gift from Susan Ferro-Novick (Yale Univer-
sity, New Haven, CT). For the pS650-specific antibody, we immunized a rab-
bit with a synthetic phosphopeptide corresponding to residues 646–654
(SWVYpSPLHYC) of human PIPKI 90. The COOH-terminal cysteine residue
was added to the peptide for affinity purification using Sulfolink gel (Pierce
Chemical Co.). The following antibodies were obtained from commercial
sources; rat mAb to HA tag (Roche); mouse mAb to Cdk5 and amphiphysin 2
(Upstate Biotechnology), to talin and tubulin (Sigma-Aldrich) and to phospho-
MAPK1/2 (New England Biolabs); rabbit polyclonal Ab to MAPK1/2 (New
England Biolabs, Inc.) and to phospho-histone H3 (Upstate Biotechnology).
DNA constructs and protein expression
Constructs of human PIPKI 87 (640 aa), PIPKI 90 (668 aa) and 28--aa
tail (641–668) of PIPKI 90, and the F3 subdomain and head domain of
talin were subcloned into pcDNA3-HA, pGEX-6P-1, or pEGFP-C2 vectors,
as described previously (Di Paolo et al., 2002; Krauss et al., 2003). We
also subcloned PIPKI 87 and PIPKI 90 into a modified version of pET15
vector (Novagen) with an NH2-terminal His6-tag. S650 in the PIPKI 90
constructs was mutated to alanine, aspartic acid, or asparagine by a
QuikChange site-directed mutagenesis kit (Promega), and the mutations
were confirmed by DNA sequencing. Full-length GST- and His6-PIPKI 90
fusion proteins expressed in Sf9 cells and Escherichia coli strain BL21, re-
spectively, were purified using glutathione-Sepharose beads (Amersham
Biosciences) and Talon metal affinity resin (BD Biosciences) following the
manufacturer’s protocols and dialyzed against TBS. Expression constructs
encoding p35, Cdk5, and mut-Cdk5 in the pCMV vector were gifts from
L.-H. Tsai (Harvard Medical School, Boston, MA). A construct of GST-inte-
grin  1 tail was a gift from J. Ylanne (University of Oulu, Oulu, Finland).
In vitro phosphorylation
p35–Cdk5 and cyclin B1–Cdk1 complexes, expressed and purified from
Sf9 cells coinfected with baculovirus encoding each component, were gifts
from Y. Kim and P. Greengard (The Rockefeller University, New York, NY)
and Y. Wang and G. Warren (Yale University), respectively. Purified GST-
PIPKI 90 or His6-PIPK 87/90 fusion proteins (200–300 ng) were incu-
bated with p35–Cdk5 complex (Lee et al., 2004) or cyclin B1–Cdk1 com-
plex (Wang et al., 2003) at an  1:1 stoichiometric ratio in the presence
of 10  Ci  -[
32P]ATP (1 Ci   37 GBq) for up to 30 min at 30
oC. PIPKI 90
phosphorylation by MAPK1 (Upstate Biotechnology) was performed ac-
cording to the manufacturer’s protocol. Kinase reactions (30–40  l final
volume) were stopped by the addition of SDS-PAGE sample buffer, and
samples were analyzed by SDS-PAGE and autoradiography. In case of
peptide phosphorylation by c-Src (Upstate Biotechnology) and p35/Cdk5,
each kinase was mixed with the 12-mer peptides (each 25  M) in the
presence of 400  M ATP and 40  Ci  -[
32P]ATP. c-Src phosphorylation
was performed in 25 mM Tris-HCl, pH 7.2, 30 mM MgCl2, 0.5 mM
EGTA, and 62.5  M Na3VO4, and p35/Cdk5 phosphorylation was as-
sayed as described above. After a 20-min incubation at 30
oC, reaction
mixtures (40  l) were stopped by adding 20  l of 40% TCA solution, and
a portion of reaction mixtures (25  l) was spotted onto P81 phosphocellu-
lose paper (Whatman). All reactions were in the linear range and con-
sumed  1% of peptide substrates. After washing five times with 0.75%
phosphoric acid and once with acetone, radiolabeling of the peptides
was quantified by Cerenkov counting.
Identification of phosphorylation sites and 2-D peptide mapping
12  g His6-PIPK 90 labeled with  -[
32P]ATP by p35–Cdk5, as described
in the previous paragraph, was excised from SDS-PAGE and digested
with trypsin (Lee et al., 2004). The resulting peptides were separated by
HPLC and detected by Cerenkov counting. Peptide masses containing a
phosphate group were determined by MALDI/MS, and the phosphoryla-
tion sites were confirmed by further radio sequencing of the peptides. 2-D
phosphopeptide mapping was performed as previously described (Hsieh-
Wilson et al., 2003). In brief, after centrifugation of the trypsin-digested
radiolabeled material, supernatants were collected and lyophilized. Pel-
lets were then washed with distilled water and running buffer (10% acetic
acid and 1% pyridine in water) several times. Lyophilized pellets were dis-
solved in running buffer and spotted onto cellulose TLC plates. The plates
were sequentially subjected to electrophoresis in the running buffer, pH
3.5, at 400 V, and then to chromatography in a buffer (25% 1-butanol,
7.5% acetic acid, and 37.5% pyridine in water). After drying the plates,
autoradiography was performed.
In vitro talin-binding assay and ITC
The talin overlay assay was performed as described previously (McPher-
son et al., 1994). 100–200 ng of purified His6-PIPKI 90 fusion proteins
transferred onto nitrocellulose membranes were incubated without or with
GST-F3 fusion protein (2  g/ml). Membranes were blotted with anti-GST
antibody. For the pull-down assay from rat brain extracts, His6-PIPKI 90 fu-
sion proteins (4–5  g) coupled to Talon metal affinity beads in TBS con-
taining 1% (vol/vol) Triton X-100 were mixed with rat brain extracts (6.4
mg) prepared in buffer A (20 mM Hepes, pH 7.4, 120 mM KCl, 1 mM
DTT, 1 mM EDTA, 1 mM EGTA, 1 mM Na3VO4, 1 mM PMSF, and 1%
[vol/vol] Triton X-100) for 3 h at 4
oC. ITC measurements were performed
using a Microcal VP-ITC isothermal titration calorimeter equipped with a
PC running VPViewer software. Dissociation constant values were ob-
tained from the data collected automatically and analyzed with Origin
software. In each experiment, 3- l aliquots of peptide solution (1 mM)
were injected into a calorimetric cell preloaded with 1.4267 ml GST-talin
head domain (16.4  M) using a rotating stirrer syringe (250- l vol) everyJCB • VOLUME 168 • NUMBER 5 • 2005 798
250 s at 37 C. All solutions included 20 mM sodium phosphate, pH 7.4,
and 150 mM NaCl and were degassed. To estimate a blank heat effect
associated with dilution and mechanical phenomena, peptide injections
were performed after saturation of binding.
Cell culture, transfection, and immunoprecipitation
CHO cells were grown in DMEM supplemented with 10% FBS and antibi-
otics and transfected for 24 h with expression constructs of WT or mutants
of HA-PIPKI 90 and of GFP-PIPKI 90, p35, Cdk5 or mut-Cdk5 using Lipo-
fectamine 2000 (Life Technologies) according to the instruction manual.
For immunoprecipitation of PIPKI 90 and talin, the cell lysates prepared in
the buffer A were incubated with anti-PIPKI 90 and antitalin antibodies for
3 h at 4
oC, and then were incubated with protein A– and protein G–Seph-
arose beads (Amersham Biosciences) for 2 h, respectively. Cell lysates
and bound materials washed with the buffer A five times were analyzed
by SDS-PAGE and Western blotting. A similar protocol was used for the
affinity chromatography of talin from transfected CHO cells on the GST-
integrin  1 tail, except that glutathione Sepharose beads were used.
Synaptosomes
Rat brain synaptosomes were prepared as described previously (Bauer-
feind et al., 1997; Lee et al., 2004). In brief, 200- l aliquots of synapto-
somes were preincubated in the “control buffer” with or without Ca
2  for
20 min at 37
oC, and then diluted with an equal volume of either control
buffer or stimulation buffer containing high K
 . When inhibitors of protein
kinases and phosphatases were used, the inhibitors were present during
both the preincubation and the stimulation steps. For analysis of total
phosphorylation of PIPKI 90, synaptosomes were labeled with 2 mCi/
ml  -[
32P]orthophosphate for 1 h prior to the preincubation. After a 1-min
stimulation, 100  l of buffer B (20 mM Hepes, pH 7.4, 50 mM NaCl, 50 mM
Na3PO4, 50 mM NaF, 5 mM EDTA, 5 mM EGTA, 5 mM  -glycerophos-
phate, 1 mM PMSF, and 1% Triton X-100 [vol/vol]) supplemented with
10% SDS (final 2% SDS) was directly added to synaptosomes for lysis and
incubation mixtures were boiled for 10 min. For repolarization, synapto-
somes stimulated by high K
  were rapidly harvested, resuspended in
control buffer, and were further incubated for 15 min before lysis. For
PIPKI 90 immunoprecipitation, synaptosomal lysates were diluted with 9
vol of the buffer B and added to protein A–Sepharose beads precoated
with anti-PIPKI 90 antibody for 2 h at 4
oC. Western blotting or autora-
diography of synaptosomal lysates and PIPKI 90 immunoprecipitates
were performed after SDS-PAGE.
Mitotic synchronization
U87MG cells were grown in minimum essential medium with Earle’s salts
supplemented with 10% FBS, 0.1 mM nonessential amino acids, 2 mM
L-glutamine, 1 mM sodium pyruvate, 0.15% sodium bicarbonate, and an-
tibiotics. To prepare both mitotic and G1 interphase cells, subconfluent
U87MG cells were treated with 250 ng/ml nocodazole (Sigma-Aldrich)
for 18 h (Chen et al., 1999). Mitotic cells released into culture medium
were collected by mechanical shake-off and washed with PBS. To harvest
G1 interphase cells, the mitotic cells were replated into fresh culture me-
dium and further incubated for 10 h. CHO cells transfected with HA-
PIPKI 90 constructs were processed as described above. Preparation of
cell lysates in the buffer A, PIPKI 90 immunoprecipitation, SDS-PAGE, and
Western blotting were performed as described above.
Immunofluorescence
Immunofluorescence of transfected NIH3T3 cells was performed as de-
scribed previously (Di Paolo et al., 2002). Fluorescence was visualized
with a microscope (Axioplan 2; Carl Zeiss MicroImaging, Inc.) equipped
with a cooled CCD camera (Orca ER2; Hamamatsu) using a Plan-Apo-
chromat (63 , 1.4 NA) oil immersion objective at room temperature. Im-
ages were acquired with Metamorph software (Universal Imaging) and
processed using Adobe Photoshop.
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